We demonstrated that, in contrast to classical opioid receptors, ACKR3 doesn't bring about classical G protein signaling and is not modulated through the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists including naloxone. Alternatively, we proven that LIH383, an ACKR3-selective subnanomolar competitor https://lukasotnld.alltdesign.com/a-review-of-conolidine-51164343